Literature DB >> 7499235

In vivo assembly of the proteasomal complexes, implications for antigen processing.

Y Yang1, K Früh, K Ahn, P A Peterson.   

Abstract

The multicatalytic and multisubunit proteasomal complexes have been implicated in the processing of antigens to peptides presented by class I major histocompatibility complex molecules. Two structural complexes of this proteinase, 20 S and 26 S proteasomes, have been isolated from cells. By analyzing in vivo assembly of the proteasomal complexes we show that the 20 S proteasomal complexes are irreversibly assembled via 15 S assembly intermediates containing unprocessed beta-type subunits. The 20 S proteasomes further associate reversibly with proteasome activators PA28 or pre-existing ATPase complexes to form 26 S proteasomal complexes. Our findings that not all of the 20 S proteasomal complexes are assembled into 26 S proteasomal complexes within cells and that all of PA28 and ATPase complexes are associated with 20 S proteasomes strongly suggest that all proteasomal complexes coexist within cells. We further demonstrate that 26 S proteasomal complexes are predominantly present in the cytoplasm and a significant portion of the 20 S proteasomal complexes is associated with the endoplasmic reticulum membrane. Taken together, our findings suggest that depending upon their associated regulatory components, 26 S and 20 S-PA28 proteasomal complexes serve different housekeeping functions within the cells, while they degrade antigens in a cooperative manner in antigen processing.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499235     DOI: 10.1074/jbc.270.46.27687

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  gamma-Interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation.

Authors:  S Bose; P Brooks; G G Mason; A J Rivett
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

Review 2.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

3.  Characterization and regulation of the major histocompatibility complex-encoded proteins Hsp70-Hom and Hsp70-1/2.

Authors:  A M Fourie; P A Peterson; Y Yang
Journal:  Cell Stress Chaperones       Date:  2001-07       Impact factor: 3.667

4.  Synthetic peptide-based activators of the proteasome.

Authors:  S Wilk; W E Chen
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

5.  Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon.

Authors:  Suchira Bose; Fiona L L Stratford; Kerry I Broadfoot; Grant G F Mason; A Jennifer Rivett
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

6.  Global organization and function of mammalian cytosolic proteasome pools: Implications for PA28 and 19S regulatory complexes.

Authors:  Toru Shibatani; Eric J Carlson; Fredrick Larabee; Ashley L McCormack; Klaus Früh; William R Skach
Journal:  Mol Biol Cell       Date:  2006-09-20       Impact factor: 4.138

7.  Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits.

Authors:  D Nandi; E Woodward; D B Ginsburg; J J Monaco
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

8.  Localization of the 26S proteasome during mitosis and meiosis in fission yeast.

Authors:  C R Wilkinson; M Wallace; M Morphew; P Perry; R Allshire; J P Javerzat; J R McIntosh; C Gordon
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

Review 9.  Molecular architecture and assembly of the eukaryotic proteasome.

Authors:  Robert J Tomko; Mark Hochstrasser
Journal:  Annu Rev Biochem       Date:  2013-03-13       Impact factor: 23.643

10.  Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.

Authors:  K B Hendil; S Khan; K Tanaka
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.